Evolent Health Valuation
| EVH Stock | USD 29.62 0.02 0.07% |
At this time, the firm appears to be undervalued. Evolent Health shows a prevailing Real Value of $34.22 per share. The current price of the firm is $29.62. Our model computes the value of Evolent Health from reviewing the firm fundamentals such as Current Valuation of 4.01 B, shares outstanding of 113.89 M, and Profit Margin of (0.06) % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise purchasing undervalued instruments and trading away overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Evolent Health's valuation include:
Price Book 3.214 | Enterprise Value 4 B | Enterprise Value Ebitda (156.69) | Price Sales 1.7473 | Forward PE 21.7391 |
Undervalued
Today
Please note that Evolent Health's price fluctuation is very steady at this time. Calculation of the real value of Evolent Health is based on 3 months time horizon. Increasing Evolent Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Evolent Health is useful when determining the fair value of the Evolent stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Evolent Health. Since Evolent Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evolent Stock. However, Evolent Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.62 | Real 34.22 | Target 46.78 | Hype 29.62 | Naive 30.02 |
The real value of Evolent Stock, also known as its intrinsic value, is the underlying worth of Evolent Health Company, which is reflected in its stock price. It is based on Evolent Health's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Evolent Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Evolent Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Evolent Health helps investors to forecast how Evolent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evolent Health more accurately as focusing exclusively on Evolent Health's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Evolent Health's intrinsic value based on its ongoing forecasts of Evolent Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Evolent Health's closest peers. When choosing an evaluation method for Evolent Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Evolent Health Investments |
|
Evolent Valuation Trend
Knowing Evolent Health's actual value is paramount for traders to make sound investment determinations. Evolent Health's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Evolent Health's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Evolent Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Evolent Market Cap
Evolent Health is rated # 5 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 61.06 Billion. Evolent Health holds roughly 3.37 Billion in market capitalization claiming about 6% of equities under Health Care industry.Evolent Health Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Evolent Health's current stock value. Our valuation model uses many indicators to compare Evolent Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolent Health competition to find correlations between indicators driving Evolent Health's intrinsic value. More Info.Evolent Health is rated # 4 in price to earning category among related companies. It is rated # 5 in price to book category among related companies . The Evolent Health's current Price To Book Ratio is estimated to increase to 3.61. Comparative valuation analysis is a catch-all model that can be used if you cannot value Evolent Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evolent Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolent Health's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Evolent Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Evolent Health and how it compares across the competition.
About Evolent Health Valuation
The stock valuation mechanism determines the current worth of Evolent Health on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Evolent Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Evolent Health based exclusively on its fundamental and basic technical indicators. By analyzing Evolent Health's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Evolent Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evolent Health. We calculate exposure to Evolent Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evolent Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 460.5 M | 230.9 M | |
| Pretax Profit Margin | (0.10) | (0.1) | |
| Operating Profit Margin | (0.04) | (0.04) | |
| Net Loss | (0.06) | (0.05) | |
| Gross Profit Margin | 0.23 | 0.23 |
8 Steps to conduct Evolent Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Evolent Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Evolent Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Evolent Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Evolent Health's revenue streams: Identify Evolent Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Evolent Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Evolent Health's growth potential: Evaluate Evolent Health's management, business model, and growth potential.
- Determine Evolent Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Evolent Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Evolent Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Evolent Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 111.3 M | |
| Forward Price Earnings | 21.7391 |
Evolent Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Evolent Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Evolent we look at many different elements of the entity such as Evolent's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Evolent Health's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Evolent Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Evolent Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Evolent Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Evolent Health's worth.When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 17.653 | Quarterly Revenue Growth 0.454 | Return On Assets 0.0086 | Return On Equity (0.11) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.